This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlson, W. Articles by Haber, E. Search for Related Content PubMed PubMed Citation Articles by Carlson, W. Articles by Haber, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ASPARTIC ACID

Hypertension, Vol 7, 13-26, Copyright © 1985 by American Heart Association

ARTICLES

Construction of a model for the three-dimensional structure of human renal renin

W Carlson, M Karplus and E Haber

The aspartyl proteases that have had their complete three-dimensional structures determined by x-ray diffraction techniques exhibit a high degree of structural homology and a correspondingly high degree of sequence homology. Using this homology, we constructed a model for the three-dimensional structure of human renal renin. We then refined and evaluated the model with the energy refinement program called CHARMM. We found that the model for human renin differs from that of mouse submaxillary gland renin in certain features, which may account for the differences in substrate specificity and antibody binding. Amino acid differences between human and mouse renin in the regions that bind the P1' side chain of the substrate appear to change only the shape of the S1' subsite of the enzyme, so that either valine or leucine side chains of the substrate can be accommodated by human renin. Amino acids in the solvent-accessible surface of the 75-85 flap appear to be distinctly different between the two structures and could account for the differences observed in antibody binding to human and mouse renin.

This article has been cited by other articles:

				H. Kasahara, E. Matsuura, K. Kaihara, D. Yamamoto, K. Kobayashi, J. Inagaki, K. Ichikawa, A. Tsutsumi, S. Yasuda, T. Atsumi, et al. Antigenic structures recognized by anti-{beta}2-glycoprotein I auto-antibodies Int. Immunol., December 1, 2005; 17(12): 1533 - 1542. [Abstract] [Full Text] [PDF]

				E. Matsuura, J. Inagaki, H. Kasahara, D. Yamamoto, T. Atsumi, K. Kobayashi, K. Kaihara, D. Zhao, K. Ichikawa, A. Tsutsumi, et al. Proteolytic cleavage of {beta}2-glycoprotein I: reduction of antigenicity and the structural relationship Int. Immunol., August 1, 2000; 12(8): 1183 - 1192. [Abstract] [Full Text] [PDF]

				D. S. Shin, C. M. Compadre, S. J. Maleki, R. A. Kopper, H. Sampson, S. K. Huang, A. W. Burks, and G. A. Bannon Biochemical and Structural Analysis of the IgE Binding Sites on Ara h1, an Abundant and Highly Allergenic Peanut Protein J. Biol. Chem., May 29, 1998; 273(22): 13753 - 13759. [Abstract] [Full Text] [PDF]

				M. D. Brown, G. E. Moore, M. T. Korytkowski, S. D. McCole, and J. M. Hagberg Improvement of Insulin Sensitivity by Short-term Exercise Training in Hypertensive African American Women Hypertension, December 1, 1997; 30(6): 1549 - 1553. [Abstract] [Full Text]

				A. Sielecki, K Hayakawa, M Fujinaga, M. Murphy, M Fraser, A. Muir, C. Carilli, J. Lewicki, J. Baxter, and M. James Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution Science, March 10, 1989; 243(4896): 1346 - 1351. [Abstract] [PDF]